Tüdőrák: vizsgálatok itt: Franciaország
318 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleStudy of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
- Where
- Angers, Bordeaux, Boulogne-Billancourt, Bron, Creteil Cedex, Dijon, Lille Cedex, Lyon, Marseille, Montpellier, Nantes Cedex 2, Paris, Paris Cedex 20, Saint-Herblain, Toulouse
- Életkor
- 18 év and over
- People
- 686 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06899126 · EU 2024-515658-26-00 - 1. fázisTaking peopleA Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
- Where
- Saint-Herblain Cedex, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 40 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07140016 · EU 2025-522398-12-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
- Where
- Dijon, Grenoble Cedex 9, Limoges, Nice Cedex 2, Paris, Pessac, Quimper Cedex, Reims, Villefranche Sur Saone Cedex
- Életkor
- 18 év and over
- People
- 750 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07361510 · EU 2025-523586-18-00 - 2. fázisTaking peopleA Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Where
- Marseille, Montpellier, Montpellier Cedex 5, Nice Cedex 2, Paris, Saint-Herblain, Villejuif
- Életkor
- 18 év and over
- People
- 160 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07680764 · EU 2026-525170-19-00 - No phaseTaking peopleCognition and Patients With Lung Cancer
- Where
- Paris
- Életkor
- 18 év to 74 év
- People
- 90
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07160751 - 1. fázisNot yet taking people in FranciaországA phase I study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in patients with solid tumors
- Where
- Lyon, Marseille
- Életkor
- 18 év and over
- People
- 64 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-518348-19-00 - 2. fázisTaking peopleNeoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- Where
- Avignon, Bordeaux Cedex, Limoges, Quimper Cedex, Rouen Cedex, Suresnes, Toulon Cedex 9
- Életkor
- 18 év to 95 év
- People
- 630 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05061550 · EU 2023-508852-21-00 - No phaseTaking peopleShort-term Effects of Osteopathic Manipulations on Heart Rate Variability in Lung Cancer Patients - A Randomized Pilot Study
- Where
- Avignon
- Életkor
- 18 év and over
- People
- 80
- Run by
- Centre Hospitalier Henri Duffaut - Avignon
See details and how to joinNCT06822348 - 3. fázisTaking peopleStudy of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer
- Where
- Angers, Créteil, La Tronche, Lyon, Marseille, Paris, Pessac, Rennes, Saint-Herblain, Saint-Mandé, Strasbourg
- Életkor
- 18 év and over
- People
- 695 worldwide
- Run by
- Gilead Sciences
See details and how to joinNCT06801834 - 3. fázisTaking peopleA Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell Lung Cancer
- Where
- Angers, Avignon Cedex 9, Bordeaux, Bron, Créteil, Grenoble Cedex 9, Le Mans Cedex 9, Lille, Limoges Cedex 1, Lyon, Lyon Cedex 04, Marseille, Montpellier Cedex 5, Paris, Pierre-Bénite, Quimper Cedex, Saint-Herblain, Suresnes, Toulon, Toulouse, Toulouse Cedex 9, Valenciennes, Villejuif
- Életkor
- 18 év and over
- People
- 263 worldwide
- Run by
- Zai Lab (US) LLC
See details and how to join2025-522818-23-00 - 1/2. fázisTaking peopleStudy of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Where
- Angers, Bordeaux, Boulogne-Billancourt, Bron, Caen Cedex 5, Dijon, Lille, Paris, Saint-Herblain, Suresnes, Toulouse Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 616 worldwide
- Run by
- Revolution Medicines, Inc.
See details and how to joinNCT06162221 · EU 2025-521147-21-00 - No phaseTaking peoplePRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
- Where
- Angers, Avignon, Bayonne, Bordeaux, Caen, Chambéry, Cholet, Créteil, Dijon, La Roche-sur-Yon, Lille, Lorient, Marseille, Montpellier, Paris, Perpignan, Pierre-Bénite, Rouen, Saint-Nazaire, Saint-Priest-en-Jarez, Strasbourg, Tarbes, Vandœuvre-lès-Nancy, Vannes, Villejuif
- Életkor
- 18 év and over
- People
- 600 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04790253 - 3. fázisTaking peopleA Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
- Where
- Avignon, Bron, Créteil, Le Mans, Limoges, Lyon, Montpellier, Pierre-Bénite, Quimper, Saint-Herblain, Suresnes, Toulon, Valenciennes
- Életkor
- 18 év and over
- People
- 480 worldwide
- Run by
- Zai Lab (Shanghai) Co., Ltd.
See details and how to joinNCT07218146 - 2. fázisTaking peopleA Study of Novel Combinations in Non-Small Cell Lung Cancer (NSCLC)
- Where
- Avignon, Rennes, Suresnes
- Életkor
- 18 év and over
- People
- 278 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07098338 · EU 2025-524843-11-00 - 3. fázisTaking peopleFunctional Lung Avoidance Planning Guided by Lung Perfusion PET/CT Versus Anatomical Planning for Lung Stereotactic Body Radiotherapy
- Where
- Brest, Lyon
- Életkor
- 18 év and over
- People
- 418
- Run by
- University Hospital, Brest
See details and how to joinNCT07289646 - 1. fázisTaking peopleKO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Where
- Lyon, Paris, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06026410 · EU 2024-513285-19-00 - 3. fázisFelfüggesztveSafety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- Where
- Angers, Bordeaux, Caen, Paris, Rennes Cedex 9, Saint-Herblain Cedex, Toulon
- Életkor
- 18 év and over
- People
- 621 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT06712355 · EU 2024-515765-34-00 - 2. fázisTaking peopleAn Open-Label, Phase 2b, Global Multicenter Cohort Trial to Assess the Safety and Efficacy of Zipalertinib in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Exon 20 Insertion and Uncommon/Single or Compound Epidermal Growth Factor Receptor Mutations
- Where
- Boulogne-Billancourt, Caen Cedex 9, Limoges, Lyon, Marseille, Paris, Pessac, Saint-Herblain, Strasbourg Cedex
- Életkor
- 18 év and over
- People
- 117 worldwide
- Run by
- Taiho Oncology Inc.
See details and how to join2023-503865-48-00 - 2/3. fázisNot yet taking people in FranciaországIZABRIGHT-Lung01: Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer after failure of EGFR TKI Therapy
- Where
- Angers, Bron, Grenoble Cedex 09, Marseille, Paris, Paris Cedex 20, Saint-Herblain, Strasbourg Cedex, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 173 worldwide
- Run by
- Bristol-Myers Squibb Services Unlimited Company
See details and how to join2025-521908-22-00 - 3. fázisFelfüggesztveA Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
- Where
- Angers, Bordeaux Cedex, Boulogne-Billancourt, Bron, Caen Cedex 9, Créteil, Le Mans Cedex 9, Lyon, Lyon Cedex 04, Mulhouse, Nantes Cedex 2, Nimes Cedex 9, Paris, Paris Cedex 18, Pierre-Bénite, Rennes, Rouen Cedex, Saint-Herblain, Villefranche Sur Saone Cedex, Villejuif
- Életkor
- 18 év and over
- People
- 360 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT07128199 · EU 2025-521775-31-00 - No phaseTaking peopleStudy of Three Endpoints to Assess the Benefit of Rehabilitation in Patients With Advanced Non-small Cell Lung Cancer Controlled After at Least 6 Months of Systemic Treatment
- Where
- Annecy, Chambéry, Grenoble
- Életkor
- 18 év and over
- People
- 63
- Run by
- University Hospital, Grenoble
See details and how to joinNCT07434947 - 2. fázisNot yet taking people in FranciaországA Study to Assess The Safety and Tolerability of Pumitamig-Based Therapy Administered Before Surgery in Participants With Early-Stage Non-Small Cell Lung Cancer (ROSETTA Lung-220)
- Where
- Paris, Rennes, Toulouse, Villejuif
- Életkor
- 18 év and over
- People
- 80 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07871214 - 1. fázisTaking peopleStudy of Elironrasib (RMC-6291) and Daraxonrasib (RMC-6236) With Other Anti-Cancer Agents in Patients With RAS G12C-Mutated NSCLC - Subprotocol A
- Where
- Bordeaux, Bron, Caen Cedex 5, Dijon, Lille, Paris, Saint-Herblain, Suresnes, Toulouse Cedex 9, Villejuif
- Életkor
- 18 év and over
- People
- 330 worldwide
- Run by
- Revolution Medicines Inc.
See details and how to join2023-509571-16-00 - No phaseTaking peopleEuropean Real-World Registry for Use of the Ion Endoluminal System
- Where
- Brest, Le Plessis-Robinson, Rouen
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- Intuitive Surgical
See details and how to joinNCT06923774 - 1. fázisTaking peoplePhase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors
- Where
- Vandœuvre-lès-Nancy
- Életkor
- 18 év and over
- People
- 180 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07261631